Novartis shares jumped on Tuesday after the Swiss drugmaker raised its full-year guidance on strong drug sales and announced a $15 billion share buyback. The company made both announcements as …
Jay Reinstein, who suffers from Alzheimer’s, sits on a bed after receiving a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson Chávez …
Supporters hold up Save Medicaid signs during the Senate Democrats’ news conference at the Capitol with disability advocates to oppose the Republicans’ Graham-Cassidy health care bill. Bill Clark | CQ-Roll …
Jay Reinstein, who suffers from Alzheimer’s, receives an injection so he can have a PET scan at MedStar Georgetown University Hospital in Washington, DC on June 20, 2023. Michael Robinson …
The Food and Drug Administration (FDA) fully approved the Alzheimer’s treatment Leqembi on Thursday, marking a significant expansion in access to the costly drug for older Americans. Medicare announced that …
The Alzheimer’s drug Leqembi is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai | via Reuters Medicare has agreed to pay for the Alzheimer’s …
Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images The Food and Drug Administration on Monday approved AstraZeneca and Sanofi‘s shot that protects infants and …
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Monday said it applied for full U.S. Food and …
Bill Ackman said in 2021 that delaying Covid vaccinations for older Americans “seems like genocide.” Today, the influential hedge fund chief and investor is amplifying the debunked anti-vaccine views of …
Nikos Pekiaridis | Nurphoto | Getty Images Stock Chart IconStock chart icon Novavax shares jump on news of a settlement payment from the Canadian government. It’s unclear how many doses …